カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

非侵襲的神経調節装置の世界市場2022：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

◆英語タイトル：Global Non-invasive Neuromodulation Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22NO18103）◆商品コード：GIR22NO18103
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年11月（※2025年版があります。お問い合わせください。）
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

非侵襲的神経調節装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の非侵襲的神経調節装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

非侵襲的神経調節装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の非侵襲的神経調節装置市場の主要な市場プレーヤーは以下のとおりです。
・Neuroelectrics、Magstim、NeuroCare Group、Soterix Medical、Newronika、Rogue Resolutions、Medtronic、Philips Healthcare、Shenzhen Yingchi Technology、Shenzhen Hanix United、Shanghai Qiankang Medical Care Company、TCT Research、EB Neuro SpA

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、非侵襲的神経調節装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非侵襲的神経調節装置メーカーの企業概要、2019年～2022年までの非侵襲的神経調節装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非侵襲的神経調節装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別非侵襲的神経調節装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの非侵襲的神経調節装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での非侵襲的神経調節装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および非侵襲的神経調節装置の産業チェーンを掲載しています。
・第13、14、15章では、非侵襲的神経調節装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 非侵襲的神経調節装置の概要
- 種類別分析（2017年vs2021年vs2028年）：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の非侵襲的神経調節装置市場規模・予測
- 世界の非侵襲的神経調節装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Neuroelectrics、Magstim、NeuroCare Group、Soterix Medical、Newronika、Rogue Resolutions、Medtronic、Philips Healthcare、Shenzhen Yingchi Technology、Shenzhen Hanix United、Shanghai Qiankang Medical Care Company、TCT Research、EB Neuro SpA
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他
・用途別分析2017年-2028年：病院、診療所、その他
・非侵襲的神経調節装置の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・非侵襲的神経調節装置のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・非侵襲的神経調節装置のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非侵襲的神経調節装置の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・非侵襲的神経調節装置の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Non-invasive Neuromodulation Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-invasive Neuromodulation Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-invasive Neuromodulation Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transcranial Direct Current Stimulation (tDCS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-invasive Neuromodulation Device include Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, and Newronika, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-invasive Neuromodulation Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Non-invasive Neuromodulation Device market are listed below:
Neuroelectrics
Magstim
NeuroCare Group
Soterix Medical
Newronika
Rogue Resolutions
Medtronic
Philips Healthcare
Shenzhen Yingchi Technology
Shenzhen Hanix United
Shanghai Qiankang Medical Care Company
TCT Research
EB Neuro SpA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-invasive Neuromodulation Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-invasive Neuromodulation Device, with price, sales, revenue and global market share of Non-invasive Neuromodulation Device from 2019 to 2022.
Chapter 3, the Non-invasive Neuromodulation Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-invasive Neuromodulation Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-invasive Neuromodulation Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive Neuromodulation Device.
Chapter 13, 14, and 15, to describe Non-invasive Neuromodulation Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Non-invasive Neuromodulation Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-invasive Neuromodulation Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-invasive Neuromodulation Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Non-invasive Neuromodulation Device Market Size & Forecast
1.4.1 Global Non-invasive Neuromodulation Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-invasive Neuromodulation Device Sales in Volume (2017-2028)
1.4.3 Global Non-invasive Neuromodulation Device Price (2017-2028)
1.5 Global Non-invasive Neuromodulation Device Production Capacity Analysis
1.5.1 Global Non-invasive Neuromodulation Device Total Production Capacity (2017-2028)
1.5.2 Global Non-invasive Neuromodulation Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-invasive Neuromodulation Device Market Drivers
1.6.2 Non-invasive Neuromodulation Device Market Restraints
1.6.3 Non-invasive Neuromodulation Device Trends Analysis
2 Manufacturers Profiles
2.1 Neuroelectrics
2.1.1 Neuroelectrics Details
2.1.2 Neuroelectrics Major Business
2.1.3 Neuroelectrics Non-invasive Neuromodulation Device Product and Services
2.1.4 Neuroelectrics Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Magstim
2.2.1 Magstim Details
2.2.2 Magstim Major Business
2.2.3 Magstim Non-invasive Neuromodulation Device Product and Services
2.2.4 Magstim Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 NeuroCare Group
2.3.1 NeuroCare Group Details
2.3.2 NeuroCare Group Major Business
2.3.3 NeuroCare Group Non-invasive Neuromodulation Device Product and Services
2.3.4 NeuroCare Group Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Soterix Medical
2.4.1 Soterix Medical Details
2.4.2 Soterix Medical Major Business
2.4.3 Soterix Medical Non-invasive Neuromodulation Device Product and Services
2.4.4 Soterix Medical Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Newronika
2.5.1 Newronika Details
2.5.2 Newronika Major Business
2.5.3 Newronika Non-invasive Neuromodulation Device Product and Services
2.5.4 Newronika Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Rogue Resolutions
2.6.1 Rogue Resolutions Details
2.6.2 Rogue Resolutions Major Business
2.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Product and Services
2.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Non-invasive Neuromodulation Device Product and Services
2.7.4 Medtronic Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Philips Healthcare
2.8.1 Philips Healthcare Details
2.8.2 Philips Healthcare Major Business
2.8.3 Philips Healthcare Non-invasive Neuromodulation Device Product and Services
2.8.4 Philips Healthcare Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shenzhen Yingchi Technology
2.9.1 Shenzhen Yingchi Technology Details
2.9.2 Shenzhen Yingchi Technology Major Business
2.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product and Services
2.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shenzhen Hanix United
2.10.1 Shenzhen Hanix United Details
2.10.2 Shenzhen Hanix United Major Business
2.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Product and Services
2.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shanghai Qiankang Medical Care Company
2.11.1 Shanghai Qiankang Medical Care Company Details
2.11.2 Shanghai Qiankang Medical Care Company Major Business
2.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product and Services
2.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 TCT Research
2.12.1 TCT Research Details
2.12.2 TCT Research Major Business
2.12.3 TCT Research Non-invasive Neuromodulation Device Product and Services
2.12.4 TCT Research Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 EB Neuro SpA
2.13.1 EB Neuro SpA Details
2.13.2 EB Neuro SpA Major Business
2.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Product and Services
2.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-invasive Neuromodulation Device Breakdown Data by Manufacturer
3.1 Global Non-invasive Neuromodulation Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-invasive Neuromodulation Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-invasive Neuromodulation Device
3.4 Market Concentration Rate
3.4.1 Top 3 Non-invasive Neuromodulation Device Manufacturer Market Share in 2021
3.4.2 Top 6 Non-invasive Neuromodulation Device Manufacturer Market Share in 2021
3.5 Global Non-invasive Neuromodulation Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-invasive Neuromodulation Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-invasive Neuromodulation Device Market Size by Region
4.1.1 Global Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2028)
4.1.2 Global Non-invasive Neuromodulation Device Revenue by Region (2017-2028)
4.2 North America Non-invasive Neuromodulation Device Revenue (2017-2028)
4.3 Europe Non-invasive Neuromodulation Device Revenue (2017-2028)
4.4 Asia-Pacific Non-invasive Neuromodulation Device Revenue (2017-2028)
4.5 South America Non-invasive Neuromodulation Device Revenue (2017-2028)
4.6 Middle East and Africa Non-invasive Neuromodulation Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-invasive Neuromodulation Device Sales in Volume by Type (2017-2028)
5.2 Global Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
5.3 Global Non-invasive Neuromodulation Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-invasive Neuromodulation Device Sales in Volume by Application (2017-2028)
6.2 Global Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
6.3 Global Non-invasive Neuromodulation Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
7.2 North America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
7.3 North America Non-invasive Neuromodulation Device Market Size by Country
7.3.1 North America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
7.3.2 North America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-invasive Neuromodulation Device Sales by Type (2017-2028)
8.2 Europe Non-invasive Neuromodulation Device Sales by Application (2017-2028)
8.3 Europe Non-invasive Neuromodulation Device Market Size by Country
8.3.1 Europe Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2028)
9.2 Asia-Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2028)
9.3 Asia-Pacific Non-invasive Neuromodulation Device Market Size by Region
9.3.1 Asia-Pacific Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
10.2 South America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
10.3 South America Non-invasive Neuromodulation Device Market Size by Country
10.3.1 South America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
10.3.2 South America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-invasive Neuromodulation Device Sales by Type (2017-2028)
11.2 Middle East & Africa Non-invasive Neuromodulation Device Sales by Application (2017-2028)
11.3 Middle East & Africa Non-invasive Neuromodulation Device Market Size by Country
11.3.1 Middle East & Africa Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-invasive Neuromodulation Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-invasive Neuromodulation Device
12.3 Non-invasive Neuromodulation Device Production Process
12.4 Non-invasive Neuromodulation Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-invasive Neuromodulation Device Typical Distributors
13.3 Non-invasive Neuromodulation Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 非侵襲的神経調節装置の世界市場2022：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他(Global Non-invasive Neuromodulation Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 植込み型神経調節装置のグローバル市場展望 2023年-2029年：脊髄刺激、脳深部刺激、仙骨神経刺激、迷走神経刺激、胃刺激、その他
  • 非侵襲的神経調節装置の世界市場2022：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他
  • 非侵襲的神経調節装置の世界市場2022：経頭蓋直流電流刺激（tDCS）、経頭蓋交流電流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他
  • 非侵襲的圧力監視装置の世界市場2022：血圧計、肺圧計、眼圧計、頭蓋内圧計、その他
  • 非侵襲的薬物送達デバイスの世界市場2022：液体系無針注射器、粉末系無針注射器